Nathan Pulkingham, MD
Anatomic Pathology & Clinical Pathology · Whiteville, NCNPI 1588663447
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $346 and has fallen 54.2% since, to $158 in 2025.
Across 26 payments — averaging $38.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$217
- Johnson & Johnson$198
- Paratek Pharmaceuticals, Inc.$125
- Boston Scientific$100
- Gilead$82
- Adaptive Biotechnologies Corporation$55
- plus $230 from 12 others
What the payments were for
- Food & beverage$1,006100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 2 | $217 |
| Johnson & Johnson(2 entities) | 5 | $198 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Boston Scientific | 1 | $100 |
| Gilead | 3 | $82 |
| Adaptive Biotechnologies Corporation | 2 | $55 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Pharmaessentia USA Corporation | 1 | $29 |
| AstraZeneca | 1 | $24 |
| Geron Corporation | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Axonics, Inc. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
| Beigene USA, Inc. | 1 | $15 |
| Abbott | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$125
- NUZYRA$125
- OPDIVO$121
- GENERAL VASCULAR INTERVENTION$100
How this compares
$1,006 in reported general payments places this provider in the 80th percentile of 221 anatomic pathology & clinical pathology providers in North Carolina.
See all anatomic pathology & clinical pathology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Whiteville
- Cynthia GuyDurham$379K
- Xiaoxian LiGreenville$68K
- Steven CorderoPinehurst$62K
- Marilyn TelenDurham$26K
- Rajesh DashDurham$26K
- Keith KaplanCharlotte$23K
- Danielle RangeDurham$21K
- Shannon McCallDurham$21K
- Jared BlockCharlotte$19K
- Chad LivasyCharlotte$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.